New drug combo shows promise for hard-to-treat breast cancers
NCT ID NCT02393794
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study tests a combination of three drugs (cisplatin, romidepsin, and nivolumab) in people with advanced triple-negative breast cancer or breast cancer linked to BRCA gene mutations. The goal is to see if the combination can shrink tumors and control the disease. About 51 adults with measurable tumors will take part. The study is in early phases, so it focuses on finding the right dose and checking how well the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Kansas Cancer Center - Clinical Research Center
Fairway, Kansas, 66205, United States
-
University of Kansas Cancer Center - Lee's Summit
Lee's Summit, Missouri, 64064, United States
-
University of Kansas Cancer Center - North
Kansas City, Missouri, 64154, United States
-
University of Kansas Cancer Center - Overland Park
Overland Park, Kansas, 66210, United States
-
University of Kansas Cancer Center - South
Kansas City, Missouri, 64131, United States
-
University of Kansas Cancer Center - West
Kansas City, Kansas, 66112, United States
-
University of Kansas Cancer Center - Westwood
Westwood, Kansas, 66205, United States
Conditions
Explore the condition pages connected to this study.